Bringing Microfluidics into the Clinic: Lessons from COVID19 and Cancer

Abstract

Dr. Stott will share her laboratory's work using microfluidics to isolate cell-specific extracellular vesicles in cancer and infectious disease applications alongside a new approach to isolate extracellular vesicles from urine.

Bio

Professor Stott is a biomedical engineer that works at the interface of technology and clinical medicine. She has an extensive background in microfluidics, optics, and biopreservation, with a focus on applications in cancer and infectious diseases. Manipulating blood flow for the isolation of biological components has been a hallmark of her work and recent efforts include using microfluidics to separate cancer cells and extracellular vesicles. The primary goal of the Stott laboratory is to use these technologies to improve patient lives through early diagnosis and a greater understanding of how cancer spreads and kills.

Dr. Stott has >25 patents issued or pending, and her research has been highlighted in Nature, Science, CNN, MIT Technology Review, as well as the television show, Jeopardy. She serves on various advisory boards, both in academic and industrial settings. Dr. Stott has been awarded many different honors, but she is most proud of receiving the 2021 MGH Excellence in Mentorship Award.